Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
34
SIGA Quote, Financials, Valuation and Earnings
Last price:
$6.76
Seasonality move
:
7.63%
Day range:
$6.64 - $6.83
52-week range:
$4.95 - $9.62
Dividend yield:
0%
P/E ratio:
6.48x
P/S ratio:
2.80x
P/B ratio:
2.38x
Volume:
1.1M
Avg. volume:
359.7K
1-year change:
10.29%
Market cap:
$483.4M
Revenue:
$138.7M
EPS (TTM):
$1.04
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SIGA
SIGA Technologies, Inc.
|
-- | -- | -- | -- | -- |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$292.5M | $0.14 | 13.44% | 28.72% | $31.21 |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$1.2B | $1.50 | 89.86% | -58.59% | $457.00 |
|
BMRN
BioMarin Pharmaceutical, Inc.
|
$835M | $0.56 | 11.9% | 36.21% | $88.87 |
|
IMNN
Imunon, Inc.
|
-- | -$1.82 | -- | -269.06% | $21.50 |
|
SVRA
Savara, Inc.
|
-- | -$0.12 | -- | -2.6% | $10.81 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SIGA
SIGA Technologies, Inc.
|
$6.75 | -- | $483.4M | 6.48x | $0.60 | 0% | 2.80x |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$23.99 | $31.21 | $4.1B | 15.44x | $0.00 | 0% | 3.86x |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$336.19 | $457.00 | $44.6B | 148.95x | $0.00 | 0% | 12.08x |
|
BMRN
BioMarin Pharmaceutical, Inc.
|
$64.08 | $88.87 | $12.3B | 24.01x | $0.00 | 0% | 4.06x |
|
IMNN
Imunon, Inc.
|
$3.22 | $21.50 | $6.8M | -- | $0.00 | 0% | 16.43x |
|
SVRA
Savara, Inc.
|
$5.53 | $10.81 | $1.1B | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SIGA
SIGA Technologies, Inc.
|
0.43% | 1.257 | 0.13% | 7.02x |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
5.64% | 2.900 | 1.52% | 2.70x |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
79% | 1.064 | 5.64% | 2.51x |
|
BMRN
BioMarin Pharmaceutical, Inc.
|
9.17% | -0.896 | 5.87% | 2.84x |
|
IMNN
Imunon, Inc.
|
21.26% | 5.236 | 10.13% | 1.25x |
|
SVRA
Savara, Inc.
|
24.02% | -1.971 | 4.83% | 7.42x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SIGA
SIGA Technologies, Inc.
|
$1.6M | -$10.2M | 36.5% | 36.71% | -390.18% | -$10.1M |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$257M | $35.8M | 31.98% | 34.23% | 12.83% | $73.9M |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$829.3M | $131.7M | 10.18% | 107.73% | 12.01% | $140.3M |
|
BMRN
BioMarin Pharmaceutical, Inc.
|
$641.8M | $184.9M | 8.12% | 8.99% | 23.5% | $334.9M |
|
IMNN
Imunon, Inc.
|
-$167K | -$3.5M | -282.76% | -365% | -- | -$4.4M |
|
SVRA
Savara, Inc.
|
-$76K | -$30.3M | -65.99% | -78.83% | -- | -$22.5M |
SIGA Technologies, Inc. vs. Competitors
-
Which has Higher Returns SIGA or ACAD?
ACADIA Pharmaceuticals, Inc. has a net margin of -242.97% compared to SIGA Technologies, Inc.'s net margin of 25.76%. SIGA Technologies, Inc.'s return on equity of 36.71% beat ACADIA Pharmaceuticals, Inc.'s return on equity of 34.23%.
Company Gross Margin Earnings Per Share Invested Capital SIGASIGA Technologies, Inc.61.75% -$0.09 $204.4M ACADACADIA Pharmaceuticals, Inc.92.23% $0.42 $972.1M -
What do Analysts Say About SIGA or ACAD?
SIGA Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand ACADIA Pharmaceuticals, Inc. has an analysts' consensus of $31.21 which suggests that it could grow by 30.1%. Given that ACADIA Pharmaceuticals, Inc. has higher upside potential than SIGA Technologies, Inc., analysts believe ACADIA Pharmaceuticals, Inc. is more attractive than SIGA Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SIGASIGA Technologies, Inc.0 0 0 ACADACADIA Pharmaceuticals, Inc.9 6 1 -
Is SIGA or ACAD More Risky?
SIGA Technologies, Inc. has a beta of 0.958, which suggesting that the stock is 4.199% less volatile than S&P 500. In comparison ACADIA Pharmaceuticals, Inc. has a beta of 0.660, suggesting its less volatile than the S&P 500 by 33.951%.
-
Which is a Better Dividend Stock SIGA or ACAD?
SIGA Technologies, Inc. has a quarterly dividend of $0.60 per share corresponding to a yield of 0%. ACADIA Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SIGA Technologies, Inc. pays -- of its earnings as a dividend. ACADIA Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SIGA or ACAD?
SIGA Technologies, Inc. quarterly revenues are $2.6M, which are smaller than ACADIA Pharmaceuticals, Inc. quarterly revenues of $278.6M. SIGA Technologies, Inc.'s net income of -$6.4M is lower than ACADIA Pharmaceuticals, Inc.'s net income of $71.8M. Notably, SIGA Technologies, Inc.'s price-to-earnings ratio is 6.48x while ACADIA Pharmaceuticals, Inc.'s PE ratio is 15.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SIGA Technologies, Inc. is 2.80x versus 3.86x for ACADIA Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SIGASIGA Technologies, Inc.2.80x 6.48x $2.6M -$6.4M ACADACADIA Pharmaceuticals, Inc.3.86x 15.44x $278.6M $71.8M
-
Which has Higher Returns SIGA or ALNY?
Alnylam Pharmaceuticals, Inc. has a net margin of -242.97% compared to SIGA Technologies, Inc.'s net margin of 16.99%. SIGA Technologies, Inc.'s return on equity of 36.71% beat Alnylam Pharmaceuticals, Inc.'s return on equity of 107.73%.
Company Gross Margin Earnings Per Share Invested Capital SIGASIGA Technologies, Inc.61.75% -$0.09 $204.4M ALNYAlnylam Pharmaceuticals, Inc.75.6% $1.37 $3.8B -
What do Analysts Say About SIGA or ALNY?
SIGA Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Alnylam Pharmaceuticals, Inc. has an analysts' consensus of $457.00 which suggests that it could grow by 35.94%. Given that Alnylam Pharmaceuticals, Inc. has higher upside potential than SIGA Technologies, Inc., analysts believe Alnylam Pharmaceuticals, Inc. is more attractive than SIGA Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SIGASIGA Technologies, Inc.0 0 0 ALNYAlnylam Pharmaceuticals, Inc.15 7 0 -
Is SIGA or ALNY More Risky?
SIGA Technologies, Inc. has a beta of 0.958, which suggesting that the stock is 4.199% less volatile than S&P 500. In comparison Alnylam Pharmaceuticals, Inc. has a beta of 0.350, suggesting its less volatile than the S&P 500 by 65.025%.
-
Which is a Better Dividend Stock SIGA or ALNY?
SIGA Technologies, Inc. has a quarterly dividend of $0.60 per share corresponding to a yield of 0%. Alnylam Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SIGA Technologies, Inc. pays -- of its earnings as a dividend. Alnylam Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SIGA or ALNY?
SIGA Technologies, Inc. quarterly revenues are $2.6M, which are smaller than Alnylam Pharmaceuticals, Inc. quarterly revenues of $1.1B. SIGA Technologies, Inc.'s net income of -$6.4M is lower than Alnylam Pharmaceuticals, Inc.'s net income of $186.4M. Notably, SIGA Technologies, Inc.'s price-to-earnings ratio is 6.48x while Alnylam Pharmaceuticals, Inc.'s PE ratio is 148.95x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SIGA Technologies, Inc. is 2.80x versus 12.08x for Alnylam Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SIGASIGA Technologies, Inc.2.80x 6.48x $2.6M -$6.4M ALNYAlnylam Pharmaceuticals, Inc.12.08x 148.95x $1.1B $186.4M
-
Which has Higher Returns SIGA or BMRN?
BioMarin Pharmaceutical, Inc. has a net margin of -242.97% compared to SIGA Technologies, Inc.'s net margin of -3.91%. SIGA Technologies, Inc.'s return on equity of 36.71% beat BioMarin Pharmaceutical, Inc.'s return on equity of 8.99%.
Company Gross Margin Earnings Per Share Invested Capital SIGASIGA Technologies, Inc.61.75% -$0.09 $204.4M BMRNBioMarin Pharmaceutical, Inc.81.58% -$0.16 $6.7B -
What do Analysts Say About SIGA or BMRN?
SIGA Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand BioMarin Pharmaceutical, Inc. has an analysts' consensus of $88.87 which suggests that it could grow by 38.69%. Given that BioMarin Pharmaceutical, Inc. has higher upside potential than SIGA Technologies, Inc., analysts believe BioMarin Pharmaceutical, Inc. is more attractive than SIGA Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SIGASIGA Technologies, Inc.0 0 0 BMRNBioMarin Pharmaceutical, Inc.14 6 0 -
Is SIGA or BMRN More Risky?
SIGA Technologies, Inc. has a beta of 0.958, which suggesting that the stock is 4.199% less volatile than S&P 500. In comparison BioMarin Pharmaceutical, Inc. has a beta of 0.256, suggesting its less volatile than the S&P 500 by 74.362%.
-
Which is a Better Dividend Stock SIGA or BMRN?
SIGA Technologies, Inc. has a quarterly dividend of $0.60 per share corresponding to a yield of 0%. BioMarin Pharmaceutical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SIGA Technologies, Inc. pays -- of its earnings as a dividend. BioMarin Pharmaceutical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SIGA or BMRN?
SIGA Technologies, Inc. quarterly revenues are $2.6M, which are smaller than BioMarin Pharmaceutical, Inc. quarterly revenues of $786.8M. SIGA Technologies, Inc.'s net income of -$6.4M is higher than BioMarin Pharmaceutical, Inc.'s net income of -$30.7M. Notably, SIGA Technologies, Inc.'s price-to-earnings ratio is 6.48x while BioMarin Pharmaceutical, Inc.'s PE ratio is 24.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SIGA Technologies, Inc. is 2.80x versus 4.06x for BioMarin Pharmaceutical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SIGASIGA Technologies, Inc.2.80x 6.48x $2.6M -$6.4M BMRNBioMarin Pharmaceutical, Inc.4.06x 24.01x $786.8M -$30.7M
-
Which has Higher Returns SIGA or IMNN?
Imunon, Inc. has a net margin of -242.97% compared to SIGA Technologies, Inc.'s net margin of --. SIGA Technologies, Inc.'s return on equity of 36.71% beat Imunon, Inc.'s return on equity of -365%.
Company Gross Margin Earnings Per Share Invested Capital SIGASIGA Technologies, Inc.61.75% -$0.09 $204.4M IMNNImunon, Inc.-- -$1.16 $5.2M -
What do Analysts Say About SIGA or IMNN?
SIGA Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Imunon, Inc. has an analysts' consensus of $21.50 which suggests that it could grow by 567.7%. Given that Imunon, Inc. has higher upside potential than SIGA Technologies, Inc., analysts believe Imunon, Inc. is more attractive than SIGA Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SIGASIGA Technologies, Inc.0 0 0 IMNNImunon, Inc.3 1 0 -
Is SIGA or IMNN More Risky?
SIGA Technologies, Inc. has a beta of 0.958, which suggesting that the stock is 4.199% less volatile than S&P 500. In comparison Imunon, Inc. has a beta of 2.135, suggesting its more volatile than the S&P 500 by 113.504%.
-
Which is a Better Dividend Stock SIGA or IMNN?
SIGA Technologies, Inc. has a quarterly dividend of $0.60 per share corresponding to a yield of 0%. Imunon, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SIGA Technologies, Inc. pays -- of its earnings as a dividend. Imunon, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SIGA or IMNN?
SIGA Technologies, Inc. quarterly revenues are $2.6M, which are larger than Imunon, Inc. quarterly revenues of --. SIGA Technologies, Inc.'s net income of -$6.4M is lower than Imunon, Inc.'s net income of -$3.4M. Notably, SIGA Technologies, Inc.'s price-to-earnings ratio is 6.48x while Imunon, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SIGA Technologies, Inc. is 2.80x versus 16.43x for Imunon, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SIGASIGA Technologies, Inc.2.80x 6.48x $2.6M -$6.4M IMNNImunon, Inc.16.43x -- -- -$3.4M
-
Which has Higher Returns SIGA or SVRA?
Savara, Inc. has a net margin of -242.97% compared to SIGA Technologies, Inc.'s net margin of --. SIGA Technologies, Inc.'s return on equity of 36.71% beat Savara, Inc.'s return on equity of -78.83%.
Company Gross Margin Earnings Per Share Invested Capital SIGASIGA Technologies, Inc.61.75% -$0.09 $204.4M SVRASavara, Inc.-- -$0.14 $124.2M -
What do Analysts Say About SIGA or SVRA?
SIGA Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Savara, Inc. has an analysts' consensus of $10.81 which suggests that it could grow by 95.52%. Given that Savara, Inc. has higher upside potential than SIGA Technologies, Inc., analysts believe Savara, Inc. is more attractive than SIGA Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SIGASIGA Technologies, Inc.0 0 0 SVRASavara, Inc.6 0 0 -
Is SIGA or SVRA More Risky?
SIGA Technologies, Inc. has a beta of 0.958, which suggesting that the stock is 4.199% less volatile than S&P 500. In comparison Savara, Inc. has a beta of 0.336, suggesting its less volatile than the S&P 500 by 66.415%.
-
Which is a Better Dividend Stock SIGA or SVRA?
SIGA Technologies, Inc. has a quarterly dividend of $0.60 per share corresponding to a yield of 0%. Savara, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SIGA Technologies, Inc. pays -- of its earnings as a dividend. Savara, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SIGA or SVRA?
SIGA Technologies, Inc. quarterly revenues are $2.6M, which are larger than Savara, Inc. quarterly revenues of --. SIGA Technologies, Inc.'s net income of -$6.4M is higher than Savara, Inc.'s net income of -$29.6M. Notably, SIGA Technologies, Inc.'s price-to-earnings ratio is 6.48x while Savara, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SIGA Technologies, Inc. is 2.80x versus -- for Savara, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SIGASIGA Technologies, Inc.2.80x 6.48x $2.6M -$6.4M SVRASavara, Inc.-- -- -- -$29.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
